Drugs Made In America Acquisition ratios data for the quarter ended Jun 2026. These financial ratios cover 6 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|
| Efficiency | ||||||
| Assets AverageAssets Avg. | 116.68M | 234.01M | 236.42M | 238.78M | 193.41M | |
| Invested CapitalInvested Cap. | 1.08M | -7.05M | -7.15M | -7.33M | -7.26M | -7.06M |
| Leverage & Solvency | ||||||
| Debt Ratio | 2.40 | 0.00 | 0.00 | |||
| Return Ratios | ||||||
| Return on Capital Employed [ROCE]ROCE | -1.18% | -1.38% | ||||
| Return on Assets [ROA]ROA | 2.49% | 3.32% |